MedTrace Logo

Mi-thos® Transcatheter Mitral Valve Replacement(First-in-Man Study)

NCT05784337 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2023-03-24

No results posted yet for this study

Summary

To evaluate the effectiveness and safety of the Mi-thos® Transcatheter Mitral Valve Replacement System in the treatment of patients with moderate or greater mitral regurgitation who are at high risk for conventional surgery, or who are not candidates for conventional surgery.

Conditions

  • Mitral Valve Regurgitation

Interventions

DEVICE

Mi-thos® Transcatheter Mitral Valve Replacement System

Transcatheter Mitral Valve Replacement

Sponsors & Collaborators

  • Shanghai NewMed Medical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-21
Primary Completion
2023-01-10
Completion
2023-01-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05784337 on ClinicalTrials.gov